umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.
Show others and affiliations
2016 (English)In: Expert Review of Vaccines, ISSN 1476-0584, E-ISSN 1744-8395, Vol. 15, no 4Article in journal (Refereed) Published
Abstract [en]

Dengue is a public health problem in the tropics and subtropics. There are several vaccine candidates in clinical development. However, there may be gaps in the new vaccine introduction after vaccine licensure before it becomes available in developing countries. In anticipation of the first dengue vaccine candidate to be licensed, Dengue Vaccine Initiative (DVI) and, its predecessor, Pediatric Dengue Vaccine Initiative (PDVI) have been working on points for consideration to accelerate evidence-based dengue vaccine introduction, once a vaccine becomes available. In this paper, we review the history of PDVI and its successor, the DVI, and elaborate on the points of consideration for dengue vaccine introduction.

Place, publisher, year, edition, pages
2016. Vol. 15, no 4
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:umu:diva-127482DOI: 10.1586/14760584.2016.1129279PubMedID: 26651238OAI: oai:DiVA.org:umu-127482DiVA: diva2:1046481
Available from: 2016-11-14 Created: 2016-11-14 Last updated: 2016-11-14

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wilder-Smith, Annelies
In the same journal
Expert Review of Vaccines
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

ReferencesLink to record
Permanent link

Direct link